Submitted by Jennifer Fuson on Mon, 06/24/2013 - 16:51
The U.S. Supreme Court gave pharmaceutical companies another gift today, largely shielding the generic industry from lawsuits for the design of their drugs. This is the second Supreme Court decision giving the generic drug industry immunity.